| Dr Gracelynn L Howard, PHARMD | |
|
11010 W 74th Ter, Shawnee, KS 66203-4422 | |
| (913) 268-4012 | |
| Not Available |
| Full Name | Dr Gracelynn L Howard |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 11010 W 74th Ter, Shawnee, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720417637 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-13790 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gracelynn L Howard, PHARMD 11010 W 74th Ter, Shawnee, KS 66203-4422 Ph: (913) 268-4012 | Dr Gracelynn L Howard, PHARMD 11010 W 74th Ter, Shawnee, KS 66203-4422 Ph: (913) 268-4012 |
News Archive
BGI Diagnostics' NIFTY™ test becomes First NIPT based on Next Generation Sequencing Technology to be Approved by the China Food and Drug Administration (CFDA).
Avastin (bevacizumab), which is used to treat wet age-related macular degeneration – the most common cause of blindness among the elderly costs only £60 per injection. But despite trials showing it is no less effective, another drug, Lucentis, is the current official choice, even though it costs £700 per shot. Avastin is intended to treat bowel cancer, but research by the National Institute for Health Research has shown that it also works just as effectively and safely as Lucentis in treating Wet AMD.
The CLIRSPEC network is a UK Engineering and Physical Sciences Research Council (EPSRC – EP/L012952/1) funded network in clinical infrared and Raman spectroscopy. Infrared and Raman spectroscopy can identify the hallmarks of disease and distinguish between diseased and non-diseased samples based upon inherent chemistry.
OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche today announced that a Phase III study of Tarceva™ (erlotinib HCl), an investigational HER1/EGFR-inhibitor agent in previously treated patients with non-small cell lung cancer (NSCLC), met its primary endpoint of improving overall survival, with patients receiving Tarceva™ living longer than those in the placebo arm of the study.
› Verified 2 days ago
Trista Voos, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11830 W 75th St, Shawnee, KS 66214 Phone: 913-433-2359 Fax: 913-433-2365 | |
Brenden Watamaniuk, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12010 W 63rd St, Shawnee, KS 66216 Phone: 913-268-8150 | |
Kristian L Olsen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12010 W 63rd St, Shawnee, KS 66216 Phone: 913-268-8150 | |
Jonathan Bradley Brocker, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16100 W 65th St, Shawnee, KS 66217 Phone: 913-268-3545 Fax: 913-268-3828 | |
Sarah Slaughter, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23614 W 58th Ter, Shawnee, KS 66226 Phone: 913-707-6856 | |
Van B Vu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13438 W 62nd Ter, Shawnee, KS 66216 Phone: 913-962-0352 | |
Mrs. Julie Wolfe, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22700 W 55th Ter, Shawnee, KS 66226 Phone: 913-422-1825 Fax: 913-422-1079 |